Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Molecular comparison reveals distinct transcriptomic differences between uterine carcinosarcoma and papillary serous carcinoma distinguishable by DNA damage.
Journal: Gynecologic oncology
Published: April 10, 2025
Not all uterine carcinosarcomas are created equal: Survival outcomes according to molecular characterization of uterine carcinosarcoma.
Journal: Gynecologic oncology
Published: September 03, 2024
Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy.
Journal: Cancer research communications
Published: June 06, 2024
Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials.
Journal: Gynecologic oncology
Published: January 17, 2024
Molecular profiling of gestational trophoblastic neoplasia: Identifying therapeutic targets.
Journal: Gynecologic oncology
Published: November 06, 2023
Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors.
Journal: Gynecologic oncology
Published: October 27, 2023
Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes.
Journal: Gynecologic oncology
Published: October 23, 2023
The Genomic Landscape of Vulvar Squamous Cell Carcinoma.
Journal: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
Published: May 03, 2023
HER2+ endometrioid endometrial cancer possesses distinct molecular and immunologic features associated with a more active immune microenvironment and worse prognosis.
Journal: Gynecologic oncology
Published: January 24, 2023
Last Updated: 09/26/2026